Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A

Mol Cell. 1999 Apr;3(4):413-22. doi: 10.1016/s1097-2765(00)80469-4.

Abstract

Signaling pathways between cell surface receptors and the BCL-2 family of proteins regulate cell death. Survival factors induce the phosphorylation and inactivation of BAD, a proapoptotic member. Purification of BAD kinase(s) identified membrane-based cAMP-dependent protein kinase (PKA) as a BAD Ser-112 (S112) site-specific kinase. PKA-specific inhibitors blocked the IL-3-induced phosphorylation on S112 of endogenous BAD as well as mitochondria-based BAD S112 kinase activity. A blocking peptide that disrupts type II PKA holoenzyme association with A-kinase-anchoring proteins (AKAPs) also inhibited BAD phosphorylation and eliminated the BAD S112 kinase activity at mitochondria. Thus, the anchoring of PKA to mitochondria represents a focused subcellular kinase/substrate interaction that inactivates BAD at its target organelle in response to a survival factor.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis
  • Carrier Proteins / metabolism*
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Interleukin-3 / pharmacology
  • Mitochondria / enzymology*
  • Phosphorylation
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Signal Transduction
  • Tumor Cells, Cultured
  • bcl-Associated Death Protein

Substances

  • Carrier Proteins
  • Enzyme Inhibitors
  • Interleukin-3
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-Associated Death Protein
  • Cyclic AMP-Dependent Protein Kinase Type II
  • Cyclic AMP-Dependent Protein Kinases